CT HOSPITALIER UNIVERSITAIRE VAUDOIS C H U V has a total of 11 patent applications. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and Mexico. Its main competitors in its focus markets pharmaceuticals, medical technology and environmental technology are PERSICA PHARMACEUTICALS LTD, HENNEPIN LIFE SCIENCES LLC and SAITAMA DAIICHI SEIYAKU KK.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Canada | 2 | |
#3 | Mexico | 2 | |
#4 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Environmental technology | |
#4 | Biotechnology | |
#5 | Computer technology | |
#6 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Luca Ludmila | 4 |
#2 | Jordan Olivier | 4 |
#3 | Delie Florence | 4 |
#4 | Mylonaki Ioanna | 3 |
#5 | Haefliger Jacques-Antoine | 3 |
#6 | Jichlinski Patrice | 3 |
#7 | Nardelli Haefliger Denise | 2 |
#8 | Saucy Francois | 2 |
#9 | Saucy François | 2 |
#10 | Domingos Pereira Sonia | 2 |
Publication | Filing date | Title |
---|---|---|
CN105188667A | Pharmaceutical formulation for use in the treatment and/or prevention of restenosis | |
WO2013135722A1 | Method for predicting awakening in a comatose patient and computer-implemented method thereof | |
WO2013065017A2 | Platelet rich plasma (prp) and prominin-1 derived peptides stimulate lymphangiogenesis | |
WO2013001504A1 | Polymorphisms associated with non-response to a hepatitis c treatment or susceptibility to non-spontaneous hepatitis c clearance |